Correlation Between FactSet Research and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FactSet Research and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FactSet Research and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FactSet Research Systems and Pfizer Inc, you can compare the effects of market volatilities on FactSet Research and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FactSet Research with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of FactSet Research and Pfizer.

Diversification Opportunities for FactSet Research and Pfizer

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between FactSet and Pfizer is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding FactSet Research Systems and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and FactSet Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FactSet Research Systems are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of FactSet Research i.e., FactSet Research and Pfizer go up and down completely randomly.

Pair Corralation between FactSet Research and Pfizer

Considering the 90-day investment horizon FactSet Research Systems is expected to generate 1.02 times more return on investment than Pfizer. However, FactSet Research is 1.02 times more volatile than Pfizer Inc. It trades about -0.26 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.53 per unit of risk. If you would invest  44,291  in FactSet Research Systems on January 9, 2025 and sell it today you would lose (4,431) from holding FactSet Research Systems or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

FactSet Research Systems  vs.  Pfizer Inc

 Performance 
       Timeline  
FactSet Research Systems 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days FactSet Research Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Pfizer Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in May 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

FactSet Research and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FactSet Research and Pfizer

The main advantage of trading using opposite FactSet Research and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FactSet Research position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind FactSet Research Systems and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk